國立虎尾科技大學 |

Small Molecule Therapeutics for Schizophrenia

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Small Molecule Therapeutics for Schizophrenia/ edited by Sylvain Celanire, Sonia Poli.
其他作者:	Celanire, Sylvain.
面頁冊數:	VII, 323 p. 185 illus., 23 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Medicinal chemistry. -
電子資源:	https://doi.org/10.1007/978-3-319-11502-3
ISBN:	9783319115023

Small Molecule Therapeutics for Schizophrenia
Small Molecule Therapeutics for Schizophrenia[electronic resource] /edited by Sylvain Celanire, Sonia Poli. - 1st ed. 2015. - VII, 323 p. 185 illus., 23 illus. in color.online resource. - Topics in Medicinal Chemistry,131862-2461 ;. - Topics in Medicinal Chemistry,15.

Antipsychotics and the Dopamine–Serotonin Connection -- GLYT1 Inhibitors: From Hits to Clinical Candidates -- Metabotropic Glutamate Receptor 2 Activators -- Activation of the mGlu5 Receptor for the Treatment of Schizophrenia and Cognitive-Deficit-Associated Disorders -- Muscarinic Acetylcholine Receptor Activators -- Nicotinic Acetylcholine Receptor Modulators -- The Use of PDE10A and PDE9 Inhibitors for Treating Schizophrenia.

The topic-related series Topics in Medicinal Chemistry covers all relevant aspects of drug research, e.g. pathobiochemistry of diseases, identification and validation of (emerging) drug targets, structural biology, drug ability of targets, drug design approaches, chemogenomics, synthetic chemistry including combinatorial methods, bioorganic chemistry, natural compounds, high-throughput screening, pharmacological in vitro and in vivo investigations, drug-receptor interactions on the molecular level, structure-activity relationships, drug absorption, distribution, metabolism, elimination, toxicology and pharmacogenomics. Medicinal chemistry is both science and art. The science of medicinal chemistry offers mankind one of its best hopes for improving the quality of life. The art of medicinal chemistry continues to challenge its practitioners with the need for both intuition and experience to discover new drugs. Hence sharing the experience of drug research is uniquely beneficial to the field of medicinal chemistry. Drug research requires interdisciplinary team-work at the interface between chemistry, biology and medicine.

ISBN: 9783319115023

Standard No.: 10.1007/978-3-319-11502-3doiSubjects--Topical Terms:

1253747
Medicinal chemistry.

LC Class. No.: RS400-431

Dewey Class. No.: 615.19

Small Molecule Therapeutics for Schizophrenia
LDR:03019nam a22004095i 4500 001 965176
003 DE-He213
005 20200630072025.0
007 cr nn 008mamaa
008 201211s2015 gw | s |||| 0|eng d
020 $a 9783319115023 $9 978-3-319-11502-3
024 7 $a 10.1007/978-3-319-11502-3 $2 doi
035 $a 978-3-319-11502-3
050 4 $a RS400-431
072 7 $a PSB $2 bicssc
072 7 $a SCI013020 $2 bisacsh
072 7 $a PSB $2 thema
082 0 4 $a 615.19 $2 23
245 1 0 $a Small Molecule Therapeutics for Schizophrenia $h [electronic resource] / $c edited by Sylvain Celanire, Sonia Poli.
250 $a 1st ed. 2015.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2015.
300 $a VII, 323 p. 185 illus., 23 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Topics in Medicinal Chemistry, $x 1862-2461 ; $v 13
505 0 $a Antipsychotics and the Dopamine–Serotonin Connection -- GLYT1 Inhibitors: From Hits to Clinical Candidates -- Metabotropic Glutamate Receptor 2 Activators -- Activation of the mGlu5 Receptor for the Treatment of Schizophrenia and Cognitive-Deficit-Associated Disorders -- Muscarinic Acetylcholine Receptor Activators -- Nicotinic Acetylcholine Receptor Modulators -- The Use of PDE10A and PDE9 Inhibitors for Treating Schizophrenia.
520 $a The topic-related series Topics in Medicinal Chemistry covers all relevant aspects of drug research, e.g. pathobiochemistry of diseases, identification and validation of (emerging) drug targets, structural biology, drug ability of targets, drug design approaches, chemogenomics, synthetic chemistry including combinatorial methods, bioorganic chemistry, natural compounds, high-throughput screening, pharmacological in vitro and in vivo investigations, drug-receptor interactions on the molecular level, structure-activity relationships, drug absorption, distribution, metabolism, elimination, toxicology and pharmacogenomics. Medicinal chemistry is both science and art. The science of medicinal chemistry offers mankind one of its best hopes for improving the quality of life. The art of medicinal chemistry continues to challenge its practitioners with the need for both intuition and experience to discover new drugs. Hence sharing the experience of drug research is uniquely beneficial to the field of medicinal chemistry. Drug research requires interdisciplinary team-work at the interface between chemistry, biology and medicine.
650 0 $a Medicinal chemistry. $3 1253747
650 0 $a Psychopharmacology. $3 644799
650 0 $a Neurosciences. $3 593561
650 1 4 $a Medicinal Chemistry. $3 668872
700 1 $a Celanire, Sylvain. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1063187
700 1 $a Poli, Sonia. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1063188
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319115030
776 0 8 $i Printed edition: $z 9783319115016
776 0 8 $i Printed edition: $z 9783319378947
830 0 $a Topics in Medicinal Chemistry, $x 1862-2461 ; $v 15 $3 1253746
856 4 0 $u https://doi.org/10.1007/978-3-319-11502-3
912 $a ZDB-2-CMS
912 $a ZDB-2-SXC
950 $a Chemistry and Materials Science (SpringerNature-11644)
950 $a Chemistry and Material Science (R0) (SpringerNature-43709)